Skip to main content

Advertisement

SpringerLink
Log in

Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Patients with chronic rhinosinusitis (CRS) and chronic rhinosinusitis with nasal polyposis (CRSwNP) commonly present with nasal obstruction, nasal discharge, facial pressure/pain, and hyposmia of prolonged duration. Recent evidence suggests that, despite clinical similarities, CRS and CRSwNP are distinct entities with separate inflammatory pathways and cytokine profiles. Antibiotics and nasal steroids are the mainstay of treatment in CRS, whereas combination systemic and nasal steroids are the foundation of CRSwNP management. Allergy therapy may play a significant role in CRS, whereas antileukotriene therapy has demonstrated promise in CRSwNP. Although prolonged medical therapy is usually necessary with both disorders, surgery may also be required to relieve refractory symptoms, and to improve sinus aeration and nasal access for topical therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Benninger M, Ferguson B, Hadley J, et al.: Adult-chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003, 129(Suppl 3):S1-S32. Literature review and expert panel assessment of current knowledge about chronic rhinosinusitis is provided, with recommended tools for evaluating future clinical trials.

    Article  PubMed  Google Scholar 

  2. Larsen P, Tos M: Origin of nasal polyps. Laryngoscope 2004, 114:710–719.

    Article  PubMed  Google Scholar 

  3. Bachert C, Hormann K, Mosges R, et al.: An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003, 58:176–191. A broad overview of both acute and chronic rhinosinusitis, with or without polyposis, is provided, including the cytokine profiles, clinical diagnosis, and the efficacies of the various treatments from pharmacotherapy to surgery.

    Article  PubMed  CAS  Google Scholar 

  4. Kowalski ML: Rhinosinusitis and nasal polyposis in aspirinsensitive and aspirin-tolerant patients: Are they different? Thorax 2000, 55(Suppl2):S84-S86.

    Article  PubMed  Google Scholar 

  5. Jahnsen FL, Haraldsen G, Aanesen JP, et al.: Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995, 12:624–632.

    PubMed  CAS  Google Scholar 

  6. Simon HU, Youseti S, Schranz C, et al.: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997, 158:3902–3908.

    PubMed  CAS  Google Scholar 

  7. Rhyoo C, Sanders SP, Leopold DA, Droud O: Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 1999, 103:395–400.

    Article  PubMed  CAS  Google Scholar 

  8. Nonoyama T, Harada T, Shinogi J, et al.: Immunohistochemical localization of cytokines and cell adhesion molecules in maxillary sinus mucosa in chronic sinusitis. Auris Nasus Larynx 2000, 27:51–58.

    Article  PubMed  CAS  Google Scholar 

  9. Bachert C, Wagenmann M, Rudock C, et al.: The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998, 53:2–13.

    Article  PubMed  CAS  Google Scholar 

  10. Malekzadeh S, McGuire J: The new histologic classification of chronic rhinosinusitis. Curr Allergy Asthma Rep 2003, 3:221–226. Interesting and well-reasoned proposal for histologically classifying chronic rhinosinusitis, based on the inflammatory cell (and cytokine) profiles, into one type dominated by eosinophilia and polypoid changes, and another by glandular hyperplasia.

    PubMed  Google Scholar 

  11. Doyle PW, Woodham JD: Evaluation of the microbiology of chronic ethmoid sinusitis. J Clin Microbiol 1991, 29:2396–2400.

    PubMed  CAS  Google Scholar 

  12. Hoyt WH: Bacterial patterns found in surgery patients with chronic sinusitis. J Am Osteopath Assoc 1992, 92:209–212.

    Google Scholar 

  13. Hsu J, Lanza DC, Kennedy DW: Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 1998, 12:243–248.

    PubMed  CAS  Google Scholar 

  14. Biel MA, Brown CA, Levinson RM, et al.: Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1998, 107:942–945.

    PubMed  CAS  Google Scholar 

  15. Brook I, Frazier EH: Correlation between microbiology and previous sinus surgery in patients with chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 2001, 110:148–151.

    PubMed  CAS  Google Scholar 

  16. Jiang RS, Lin JF, Hsu CY: Correlation between bacteriology of the middle meatus and the ethmoid sinus in chronic sinusitis. J Laryngol Otol 2002, 116:443–446.

    Article  PubMed  Google Scholar 

  17. Finegold SM, Flynn MJ, Rose FV, et al.: Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin Infect Dis 2002, 35:428–433.

    Article  PubMed  CAS  Google Scholar 

  18. Gordts F, Halewyck S, Pierard D, et al.: Microbiology of the middle meatus: a comparison between normal adults and children. J Laryngol Otol 2000, 114:184–188.

    Article  PubMed  CAS  Google Scholar 

  19. Osguthorpe JD: Adult rhinosinusits: diagnosis and management. Am Fam Physician 2001, 63:69–76.

    PubMed  CAS  Google Scholar 

  20. Anon J, Jacobs M, Poole M, et al.: Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004, 130(1 Suppl):1–45.

    PubMed  Google Scholar 

  21. Namyslowski G, Misiolek M, Czecior E, et al.: Comparison of the efficacy and tolerability of amoxicillin/clavulanic acid 875 mg. b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother 2002, 14:508–517.

    PubMed  CAS  Google Scholar 

  22. Legent F, Bordure P, Beauvillain C, Berche P: A double-blind comparison of ciprofloxacin and amoxicillin/ clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994, 40(Suppl1):8–15.

    Article  PubMed  CAS  Google Scholar 

  23. Dellamonica P, Choutet P, Lejeune JM, et al.: Efficacy and tolerance of cefotiam hexetil in the super-infected chronic sinusitis. A randomized, double-blind study in comparison with cefixime. Ann Otolaryngol Chir Cervicofac 1994, 111:217–222.

    PubMed  CAS  Google Scholar 

  24. Sinus & Allergy Health Partnership: Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2000, 123:1–4.

    Article  Google Scholar 

  25. Norlander T, Bronnegard M, Stierna P: The relationship of nasal polyps, infection, and inflammation. Am J Rhinol 1999, 13:349–355.

    PubMed  CAS  Google Scholar 

  26. Bernstein J, Ballow M, Schlievert P, et al.: A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003, 17:321–326.

    PubMed  Google Scholar 

  27. Bachert C, Gevaert P, van Cauwenberge P: Staphylococcus aureus superantigens and airway disease. Curr Allergy Asthma Rep 2002, 2:252–258.

    Article  PubMed  Google Scholar 

  28. Schubert MS: A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001, 87:181–188. Seminal paper detailing the potential for a "superantigen" origin to some types of chronic rhinosinusitis (See Bernstein et al. [26] and Bachert et al. [27].).

    PubMed  CAS  Google Scholar 

  29. Iino Y, Sasaki Y, Kojima C, Miyazawa T: Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps. Ann Otol Rhinol Laryngol 2001, 110:457–463.

    PubMed  CAS  Google Scholar 

  30. Cervin A: The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001, 121:83–92.

    Article  PubMed  CAS  Google Scholar 

  31. Garey KW, Alwani A, Danziger LH, Rubinstein I: Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest 2003, 123:261–265.

    Article  PubMed  Google Scholar 

  32. Post JC: Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001, 111:2083–2094.

    Article  PubMed  CAS  Google Scholar 

  33. Damm M, Jungehulsing M, Eckel HE, et al.: Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 1999, 120:517–523.

    Article  PubMed  CAS  Google Scholar 

  34. Schleimer R: Glucocorticosteroids: their mechanisms of activation and use in allergic diseases. In Allergy: Principals and Practice, edn 4. Edited by Middleton EJ, Reed CE, Ellis EF, et al. St. Louis: Mosby-Year Book; 1993:893–925.

    Google Scholar 

  35. Cox G, Ohtoshi T, Vancheri C, et al.: Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991, 4:525–531.

    PubMed  CAS  Google Scholar 

  36. Senior B, Kennedy D, Tanabodee J, et al.: Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998, 108:151–157.

    Article  PubMed  CAS  Google Scholar 

  37. Allen DB, Meltzer EO, Lemanske RF, et al.: No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002, 23:407–413.

    PubMed  CAS  Google Scholar 

  38. Skoner DP, Gentile D, Angelini B, et al.: The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol 2003, 90:56–62.

    Article  PubMed  CAS  Google Scholar 

  39. Dolor RJ, Witsell DL, Hellkamp AS, et al.: Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. JAMA 2001, 286:3097–3105.

    Article  PubMed  CAS  Google Scholar 

  40. Jankowski R, Schrewelius C, Bonfils P, et al.: Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg 2001, 127:447–452.

    PubMed  CAS  Google Scholar 

  41. Filiaci F, Passali D, Puxeddu R, Schrewelius C: A randomized, controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology 2000, 38:185–190.

    PubMed  CAS  Google Scholar 

  42. Keith P, Nieminen J, Hollingworth K, Dolovich J: Efficacy and tolerability of fluticasone propionate nasal drops 400 micrograms once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000, 30:1460–1468.

    Article  PubMed  CAS  Google Scholar 

  43. Badia L, Lund V: Topical corticosteroids in nasal polyposis. Drugs 2001, 61:573–578.

    Article  PubMed  CAS  Google Scholar 

  44. El Naggar M, Kale S, Aldren C, Martin F: Effect of beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. J Laryngol Otol 1995, 109:941–944.

    Google Scholar 

  45. Holmstrom M: Clinical performance of fluticasone propionate nasal drops. Allergy 1999, 54:21–25.

    PubMed  Google Scholar 

  46. Karlsson G, Rundcrantz H: A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982, 20:144–148.

    PubMed  CAS  Google Scholar 

  47. Drettner B, Ebbesen A, Nilsson M: Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982, 20:149–158.

    PubMed  CAS  Google Scholar 

  48. Bross-Soriano D, Arrieta-Gomez J, Prado-Calleros H: Infections after endoscopic polypectomy using nasal steroids. Otolaryngol Head Neck Surg 2004, 130:319–322.

    Article  PubMed  Google Scholar 

  49. Benninger M, Hadley J, Osguthorpe JD, et al.: Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 2004, 130:5–24.

    Article  PubMed  Google Scholar 

  50. Bonfils P, Mores J, Halimi P, Avan P: Corticosteroid treatment in nasal polyposis with a three-year follow-up period. Laryngoscope 2003, 113:683–687. Presents a retrospective study of 100 patients with nasal polyposis treated with short-term oral steroids and long-term nasal steroid sprays over a 3-year period, and in which only 15% of patients required surgery.

    Article  PubMed  CAS  Google Scholar 

  51. Parnes SM: The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg 2003, 11:184–191. Provides a summary of literature regarding the role of anti-leukotrienes in the treatment of chronic rhinosinusitis, and of studies currently underway to further elucidate the efficacy of this class of medications.

    Article  PubMed  Google Scholar 

  52. Ragab S, Parikh A, Darby YC, Scadding GK: An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001, 31:1385–1391.

    Article  PubMed  CAS  Google Scholar 

  53. Parnes SM, Chuma AV: Acute effects of antileukotrienes on sinusitis and sinonasal polyposis. Ear Nose Throat J 1999, 79:18–25.

    Google Scholar 

  54. Grundmann T, Töpfner M: Leukotrienrezeptorantagonisten zur rezidivprophylaxe bei der ASS-assocziierten polyposiserste klinische ergebnisse zur wirkung auf entzundliche gewebeprozesse. Laryngol Rhinol Otol 2001, 80:576–582.

    Article  CAS  Google Scholar 

  55. Braun JJ, Alabert JP, Michel FB, et al.: Adjunct effect of loratidine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy 1997, 52:650–655.

    Article  PubMed  CAS  Google Scholar 

  56. Haye R, Aanesen JP, Burtin B, et al.: The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998, 112:1042–1046.

    PubMed  CAS  Google Scholar 

  57. Berrettini S, Carabelli A, Sellari-Franceschini S, et al.: Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999, 54:242–248.

    Article  PubMed  CAS  Google Scholar 

  58. Yariktas M, Doner F, Demirci M: Rhinosinusitis among the patients with perennial or seasonal allergic rhinitis. Asian Pac J Allergy Immunol 2003, 21:75–78.

    PubMed  Google Scholar 

  59. Ramadan HH, Fornelli R, Ortiz AO, Rodman S: Correlation of allergy and severity of sinus disease. Am J Rhinol 1999, 13:345–347.

    PubMed  CAS  Google Scholar 

  60. Bachmann G, Hommel G, Michel O: Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otolaryngol 2000, 257:537–541.

    Article  CAS  Google Scholar 

  61. Rabago D, Zgierska A, Mundt M, et al.: Efficacy of daily hypertonic saline irrigation among patients with sinusitis: a randomized controlled trial. J Fam Prac 2002, 51:1049–1055.

    Google Scholar 

  62. Davidson T, Murphy C, Mitchell M, et al.: Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995, 105:354–358.

    Article  PubMed  CAS  Google Scholar 

  63. Poinkau J, Sherris D, Kita H, Kern E: Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2003, 110:862–866. Presents a prospective study of amphotericin irrigations in the treatment of chronic rhinosinusitis, with 35% of patients becoming disease free. Further studies are necessary, but this paper provides the current literature regarding fungi and chronic rhinosinusitis.

    Article  CAS  Google Scholar 

  64. Ricchetti A, Landis B, Maffioli A, et al.: Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002, 116:261–263.

    Article  PubMed  Google Scholar 

  65. Norès J-M, Avan P, Bonfils P: Medical management of nasal polyposis: a study in a series of 152 consecutive patients. Rhinology 2003, 41:97–102.

    PubMed  Google Scholar 

  66. Osguthorpe JD: Surgical outcomes in rhinosinusitis: what we know. Otolaryngol Head Neck Surg 1999, 120:451–453.

    Article  PubMed  CAS  Google Scholar 

  67. Dursun E, Korkmaz H, Eryilmaz A, et al.: Clinical predictors of long-term success after endoscopic sinus surgery. Otolaryngol Head Neck Surg 2003, 129:526–531.

    Article  PubMed  Google Scholar 

  68. Blomqvist EH, Lundblad L, Änggard A, et al.: A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001, 107:224–228.

    Article  PubMed  CAS  Google Scholar 

  69. Garrel R, Gardiner Q, Khudjadze M, et al.: Endoscopic surgical treatment of sinonasal polyposis-medium term outcomes (mean follow-up of 5 years). Rhinology 2003, 41:91–96.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, 135 Rutledge Avenue, PO Box 250550, 29425, Charleston, SC, USA

    M. Boyd Gillespie MD & J. David Osguthorpe MD

Authors
  1. M. Boyd Gillespie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. David Osguthorpe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillespie, M.B., Osguthorpe, J.D. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis. Curr Allergy Asthma Rep 4, 478–485 (2004). https://doi.org/10.1007/s11882-004-0015-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-004-0015-3

Keywords

Search

Navigation